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Luis A. Gonano, MD; Marisa Sepu´lveda, BS; Yanina Rico, BS; Marcia Kaetzel, PhD;
Carlos A. Valverde, PhD; John Dedman, PhD; Alicia Mattiazzi, MD; Martin Vila Petroff, PhD
Background—Digitalis-induced Na1 accumulation results in an increase in Ca21i via the Na1/Ca21 exchanger, leading to
enhanced sarcoplasmic reticulum (SR) Ca21 load, responsible for the positive inotropic and toxic arrhythmogenic
effects of glycosides. A digitalis-induced increase in Ca21i could also activate calcium-calmodulin kinase II (CaMKII),
which has been shown to have proarrhythmic effects. Here, we investigate whether CaMKII underlies digitalis-induced
arrhythmias and the subcellular mechanisms involved.
Methods and Results—In paced rat ventricular myocytes (0.5 Hz), 50 mmol/L ouabain increased contraction amplitude by
16065%. In the absence of electric stimulation, ouabain promoted spontaneous contractile activity and Ca21 waves. Ouabain
activated CaMKII (p-CaMKII), which phosphorylated its downstream targets, phospholamban (PLN) (Thr17) and ryanodine
receptor (RyR) (Ser2814). Ouabain-induced spontaneous activity was prevented by inhibiting CaMKII with 2.5 mmol/L
KN93 but not by 2.5 mmol/L of the inactive analog, KN92. Similar results were obtained using the CaMKII inhibitor,
autocamtide-2 related inhibitory peptide (AIP) (1 to 2.5 mmol/L), and in myocytes from transgenic mice expressing
SR-targeted AIP. Consistently, CaMKII overexpression exacerbated ouabain-induced spontaneous contractile activity.
Ouabain was associated with an increase in SR Ca21 content and Ca21 spark frequency, indicative of enhanced SR Ca21 leak.
KN93 suppressed the ouabain-induced increase in Ca21 spark frequency without affecting SR Ca21 content. Similar results
were obtained with digoxin. In vivo, ouabain-induced arrhythmias were prevented by KN93 and absent in SR-AIP mice.
Conclusions—These results show for the first time that CaMKII mediates ouabain-induced arrhythmic/toxic effects. We
suggest that CaMKII-dependent phosphorylation of the RyR, resulting in Ca21 leak from the SR, is the underlying
mechanism involved. (Circ Arrhythm Electrophysiol. 2011;4:947-957.)
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Cardiotonic glycosides selectively bind to and inhibit thesarcolemmal Na1/K1-ATPase and cause an increase in
intracellular Na1, which in the heart reduces Ca21 extrusion
and/or increases Ca21 influx through the Na1/Ca21 ex-
changer (NCX). This increase in Ca21i leads to an increase in
sarcoplasmic reticulum (SR) Ca21 load and to a positive
inotropic effect, which explains, at least in part, their thera-
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peutic use for heart failure treatment1; however, these com-
pounds have associated arrhythmic/toxic effects that conspire
against their extensive use in the clinical practice.2 The
arrhythmic effects have been proposed to occur when the SR
Ca21 storage capacity is exceeded so that oscillations of
release-uptake cycles arise to re-establish the Ca21 equilib-
rium between the cytosol and the SR. These transient in-
creases in Ca21i (Ca21 waves) activate a transient inward
(depolarizing) current (Iti), primarily mediated by the
forward-mode NCX current. This Iti is responsible for the
generation of delayed after depolarizations (DADs), which, if
sufficiently large, may achieve threshold and generate spon-
taneous action potentials, leading to extrasystoles and ven-
tricular arrhythmias3; however, several lines of evidence
suggest that increased SR Ca21 load in itself is not sufficient
to promote diastolic spontaneous SR Ca21 release. For
example, phospholamban (PLN) knock-out mice, which have
a fully loaded SR, have not proven to be prone to arrhythmias
under basal conditions.4,5 Moreover, a recent report showed
that ouabain-induced DADs could be prevented by using
JTV-519, a putative RyR stabilizer,6 suggesting that the
underlying alteration responsible for ouabain-induced ar-
rhythmias was at the level of the RyR rather than on the SR
Ca21 load. Indeed, in addition to SR Ca21 overload, an
increase in RyR open probability, resulting in enhanced SR
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Ca21 leak, is also a well-known substrate for triggering Ca21
waves, Iti, DADs, and, eventually, arrhythmias.7
In a previous study, we showed that chronic treatment with
low nontoxic doses of the cardiotonic steroid ouabain can induce
apoptosis through a mechanism that requires CaMKII activa-
tion.8 In this study, we found that the activation of the NCX
during ouabain treatment leads to an increase in intracellular
Ca21i that results in CaMKII activation and culminates in
apoptotic cell death. The above-mentioned signaling events
could also be involved in cardiotonic steroid-induced arrhyth-
mias, given that CaMKII activation has been shown to increase
SR Ca21 load and leak and induce arrythmias9; however,
whether CaMKII contributes to glycoside-induced arrhythmias
has not been previously assessed.
The aim of this study was to examine whether cardiotonic
steroid-induced arrhythmias are CaMKII-dependent and, if so, to
determine the underlying mechanisms involved. For this pur-
pose, we assessed the spontaneous contractile activity associated
with Ca21 waves as a proximal direct index of triggered
DAD-like arrhythmias in rat myocytes, and we used transgenic
mice as an experimental tool to assess the underlying mecha-
nisms of cardiotonic steroid-triggered arrhythmias.
Methods
Myocyte Isolation and Culture
All experiments were performed in accordance with the Guide for
the Care and Use of Laboratory Animals (NIH Publication No.85-
23, revised 1996) and approved by the Institutional Animal Care and
Use Committee of La Plata University. Wistar rats (200 to 300 g),
BALB/c (wild-type [WT]), or transgenic mice with cardiomyocyte-
delimited transgenic expression of SR-targeted CaMKII inhibitor
AIP (SR-AIP) or with a double-mutant nonphosphorylated form of
phospholamban (PLN-DM), where the mutant PLN has alanine
replacing both Ser-16 (PKA site) and Thr-17 (CaMKII site) (Mutant
Mouse Regional Resource Center at the University of Missouri,
Columbia, MO) were anesthetized by an intra-abdominal injection of
sodium pentobarbitone (35 mg [Kg body weight]21). Immediately
after plane three of phase III of anesthesia was verified by the loss of
the corneal reflex and the appearance of slow deep diaphragmatic
breathing, central thoracotomy and heart excision were performed.
Myocytes were isolated by enzymatic digestion, as previously de-
scribed.10 Details can be found in the online-only Supplemental Material.
Indo-1 Fluorescence and
Cell-Shortening Measurements
Isolated myocytes were loaded with indo-1/AM (17 mmol/L for 9
minutes).10 See the online-only Supplemental Material for details of
indo-1 fluorescence and cell-shortening methods.
The propensity to develop DAD-like arrhythmias was estimated
from the number of nonstimulated contractile events (NSE). NSE
were defined as spontaneous CaiT increases with subsequent con-
tractions of myocytes.11 These spontaneous CaiT or Ca21 waves and
the associated contraction can be used as a proximal direct index of
triggered DAD-like arrhythmias.12
Confocal Imaging of Intact Cardiac Myocytes
Cells loaded with 10 mmol/L Fluo-3 were visualized using a Leica TCS
SP5 inverted confocal microscope (Leica, Germany). See the online-
only Supplemental Material for details of the confocal imaging.
Western Blot
Homogenates, cytosolic fractions, and SR membranes were prepared
from the pulverized ventricular tissue from Langendorff-perfused rat
hearts, as previously described.10 See the online-only Supplemental
Materials for details.
Adenoviral Gene Transfer and
Transfection Efficiency
Dr Roger J. Hajjar (Mount Sinai School of Medicine, New York, NY)
kindly supplied 2 first-generation type 5 recombinant adenoviruses that
were used: Ad.bgal, carrying the b-galactosidase and the green fluores-
cent protein genes, and Ad.CaMKII, carrying both the CaMKIIdC and
the green fluorescent protein genes, each under separate cytomegalovi-
rus promoters. For details of the infection of myocytes with the
adenovirus, see the online-only Supplemental Material.
In Vivo ECG Measurements
Surface ECG were recorded in BALB/c and SR-AIP mice using
standard ECG electrodes for the PowerLab 4ST data acquisition system.
Find further details in the online-only Supplemental Material.
Ouabain Doses
The concentration of ouabain used in this study (50 mmol/L) has been
previously shown to be arrhythmogenic.13 In the in vivo experiments, 10
mg/kg were injected intraperitoneally. The online-only Supplemental
Material details the rationale for using these doses.
Statistical Analysis
The unpaired student t test, Mann-Whitney rank-sum test, Fisher exact
test, 1-way ANOVA, or Kruskal-Wallis 1-way ANOVA were used for
statistical comparisons when appropriate. Differences were considered
significant at P#0.05. Parametric and nonparametric continuous data
are expressed as means6SEM and medians6percentiles, respectively,
and categorical data are summarized as percents.
Results
Ouabain Induces Spontaneous Contractile
Activity, Ca21 Waves and Activates CaMKII in
Rat Myocytes
The effect of 50 mmol/L ouabain on cell contraction and the
associated intracellular Ca21 transient (CaiT) was tested in
freshly isolated rat myocytes. The propensity for NSE and
spontaneous Ca21 waves was assessed using the protocol
depicted in Figure 1A. Myocytes, field stimulated at 0.5 Hz,
were perfused with 50 mmol/L ouabain. After 20 minutes,
stimulation was stopped, and myocyte cell length and CaiT were
monitored for an additional 10 minutes in the continuous
presence of ouabain. The continuous chart recordings show that
ouabain administration produced a typical positive inotropic
effect, associated with an increase in CaiT and the presence of a
large number of NSE and Ca21 waves during the nonstimulated
period compared with control. Overall, ouabain produced a
6065% increase in contractility (n56 myocytes from 4 hearts),
associated with a 1763% increase in CaiT amplitude (n56
myocytes from 4 hearts), and increased the number of NSE from
1164 to 68610 events/10 minutes.
We have previously demonstrated that chronic treatment
with a low dose of ouabain can activate CaMKII.8 To
evaluate whether CaMKII is also activated by acute ouabain
administration, Langendorff-perfused rat hearts were treated
for 20 minutes with 50 mmol/L ouabain and then freeze-
clamped for Western blotting. As shown in Figure 1B,
ouabain effectively increased CaMKII activity (p-CaMKII).
Furthermore, the CaMKII inhibitor, KN93, significantly re-
duced this activation (n55 hearts).
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CaMKII Mediates Ouabain-Induced
Spontaneous Activity
Figure 2 shows typical tracings of cell-shortening of myocytes
subjected to the protocol depicted in Figure 1A. As shown
earlier, in the presence of ouabain, cells develop a large number
of spontaneous contractile events during the nonstimulated
period. This ouabain-induced spontaneous activity is largely
reduced when cells are pretreated with 2.5 mmol/L of the
CaMKII inhibitor, KN93. Similar results were obtained in the
presence of 1 mmol/L of the more specific CaMKII-inhibitory
peptide, AIP (ouabain1AIP). In contrast, the number of NSE
was not reduced by the inactive KN93 analog, KN92. Similar
results were obtained in experiments performed at 37°C (data
not shown). Control experiments showed that the inhibitors used
did not significantly affect basal contractility or the number of
NSE before the administration of ouabain. The bar graph in
Figure 2B shows the overall results of these experiments and
additionally indicates that ouabain-induced NSE can be com-
pletely prevented by inhibiting SR function with ryanodine and
thapsigargin (Ry1TG), indicating a primary role for the SR in
ouabain-induced, CaMKII-dependent, spontaneous activity. In-
terestingly, CaMKII inhibition did not affect the ouabain-
induced positive inotropic effect: 168.3613.3% of control
ouabain (n513 myocytes from 6 hearts) and 159.7613.3% of
Figure 1. Ouabain activates calcium-calmodulin kinase II (CaMKII)
and induces spontaneous Ca21 release and contractile activity
in rat myocytes. A, Representative continuous recordings of cell
length and Ca21I show that ouabain produces a typical positive
inotropic effect during pacing at 0.5 Hz, and a large number of
spontaneous Ca21 releases and contractile activity during the
following nonstimulated period. Control cells in the absence of
ouabain show stable Ca21 contraction cycles during the
20-minute stimulation period and few spontaneous events in the
absence of electric stimulation. B, Representative blots and
overall results show that ouabain increases the activity of
CaMKII (p-CaMKII) and its prevention with KN93. Data are
expressed as means6SEM from 5 independent experiments
from 5 hearts. (*P,0.05, 1-way ANOVA, Newman-Keuls).
Figure 2. Calcium-calmodulin kinase II (CaMKII) inhibition pre-
vents ouabain-induced spontaneous contractile activity but does
not affect its positive inotropic effect. A, Representative continu-
ous chart recordings of cell length show that KN93 does not
prevent ouabain inotropy but reduces its spontaneous contrac-
tile activity. In contrast, the inactive analog, KN92, did not pre-
vent ouabain-induced nonstimulated contractile events (NSE).
Panel B shows average results of these experiments, indicating
that the number of ouabain-induced NSE in rat cells were signif-
icantly reduced by CaMKII inhibitors KN93 and AIP and by
inhibiting sarcoplasmic reticulum (SR) function with ryanodine
and thapsigargin but not by KN92. Data are medians6percentiles
for 6 to 14 cells from 6 hearts per group (*P,0.05, Kruskal-Wallis
1-way ANOVA, Dunn method).
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control ouabain1KN93 (n514 myocytes from 6 hearts). To
further confirm the central role played by CaMKII in ouabain-
induced spontaneous activity by nonpharmacologic means, 2
different strategies were followed: (1) we overexpressed
CaMKIIdc (Ad.CaMKII) in cultured rat myocytes by adenoviral
gene transfer, and (2) we employed transgenic mouse myocytes
expressing SR-targeted CaMKII inhibitor AIP (SR-AIP). Figure
3A shows that 24 hours after infection, rat myocytes retained
their rod shape morphology and functional integrity and presented
(nearly 100%) a robust expression of the reporter gene,
green fluorescent protein, indicating that our gene of
interest was also overexpressed. At this time, CaMKII
expression was significantly increased, as confirmed by
Western blotting (Figure 3B). Functional experiments
were then carried out to examine the susceptibility of these
cells to develop ouabain-induced NSE in comparison with
cells infected in similar conditions but with the adenovirus
carrying the b-galactosidase gene (Ad.bgal). The repre-
sentative tracings depicted in Figure 3C show that there
were no significant differences between infected groups in
the basal contraction and the NSE. Of note, spontaneous
contractile activity in the absence of ouabain was lower
than the one observed in fresh cells. The reason for this is
not apparent to us but could be because of the prolonged
culture period. As in fresh cells, ouabain increased spon-
taneous activity in both b-galactosidase and CaMKII
overexpressing cells; however, the incidence of spontaneous
contractile activity was significantly higher in Adv.CaMKII
cells. In contrast, CaMKII overexpression did not affect the
ouabain-induced positive inotropic effect. The bar graphs in
Figure 3C show the overall results of these experiments. These
data serve to confirm that CaMKII is functionally linked with
ouabain-induced NSE and arrhythmogenesis but not with
inotropy.
Consistently, myocytes isolated from WT mice show a
similar increase in the number of NSE in response to ouabain
Figure 3. Overexpression of calcium-cal-
modulin kinase II (CaMKII) enhances
ouabain-induced spontaneous activity. A,
Twenty-four hours after infection, coexpres-
sion of green fluorescent protein demon-
strates visually that b-galactosidase (left)
and CaMKII (right) are being expressed in
the cells. B, Representative blots and over-
all results of phospho-CaMKII and glyceral-
dehyde 3-phosphate dehydrogenase
(GAPDH) confirmed the overexpression
of CaMKII in Ad.CaMKII vs Ad.b-
galactosidase-infected cells. C, Represen-
tative continuous chart recordings of cell
length show that CaMKII overexpression
exacerbates ouabain-induced nonstimu-
lated contractile events (NSE). The bar
graph below depicts overall data showing
that in b-galactosidase-expressing cells,
ouabain produces few NSE during the non-
stimulated period, whereas in CaMKII-
overexpressing cells, the number of NSE
during the nonstimulated period is signifi-
cantly exacerbated with respect to Adv.b-
galactosidase-infected cells. CaMKII over-
expression did not significantly affect
ouabain inotropy. Data are medians6
percentiles for n56 cells from 3 hearts per
group (*P,0.05, Kruskal-Wallis 1-way
ANOVA, Dunn method).
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as rat cells; however, ouabain failed to increase the incidence
of spontaneous contractile activity in SR-AIP mice myocytes
(Figure 4A). Overall results show that ouabain significantly
increases the number of NSE in WT controls and that these
events evoked by ouabain do not significantly increase in
SR-AIP cells (Figure 4B). Figure 4C shows that ouabain
produced a similar positive inotropic effect in myocytes
isolated from WT or SR-AIP mice.
Mechanisms Underlying CaMKII-Mediated
Ouabain-Induced Arrhythmias
Ca21 waves generate spontaneous contractions, but, more
importantly, they are also the substrate for DAD-triggered
arrhythmias, which are thought to be responsible for digitalis
intoxication.14,15 At least 2 factors have been shown to
underlie spontaneous SR Ca21 release or Ca21 waves: (1) an
increase in SR Ca21 load and (2) an increase in the sensitivity
of the RyR for Ca21 release.7,15 CaMKII has been shown to
enhance both these processes,16,17 suggesting its potential
involvement in cardiotonic steroid (CTS)-induced arrhyth-
mias; however, whether CaMKII favors ouabain-induced
arrhythmogenicity by affecting SR Ca21 load, the sensitivity
of the RyR for Ca21 release, or both these mechanisms, is
unknown.
Effect of CaMKII Inhibition on Ouabain-Induced
Increase in SR Ca21 Load
Figure 5A shows the effect of ouabain on the phosphorylation
of the CaMKII-dependent PLN residue, Thr17. Ouabain
significantly increased Thr17 phosphorylation, and this effect
was prevented by 2.5 mmol/L KN93. The traces in Figure 5B
show the effect of ouabain in the absence and presence of
KN93 on caffeine-induced Ca21 transients, performed to
evaluate SR Ca21 content. As previously reported by us and
others,8,15 ouabain significantly increases SR Ca21 content;
however, KN93 failed to affect caffeine-induced SR Ca21
release. On average, SR Ca21 load increased by 2565% in
the presence of ouabain (n56 from 3 hearts) and by 2466%
in the presence of ouabain 12.5 mmol/L KN93 (n58 from 4
hearts). These results suggest that although ouabain enhances
PLN phosphorylation, which would increase SERCA2a ac-
tivity and favor SR Ca21 load, this mechanism is not required
for the observed increase in SR Ca21 content produced by
ouabain challenge. To further assess whether ouabain-
induced CaMKII-dependent PLN phosphorylation is in-
volved in the generation of spontaneous contractile activity,
and therefore in Ca21 waves and DADs, we used PLN
double-mutant (PLN-DM) mouse myocytes. Figure 5C shows
overall results, indicating that ouabain significantly and
similarly increased the number of NSE in both WT and
PLN-DM myocytes, suggesting that targets other than PLN
are involved in ouabain-induced, CaMKII-dependent sponta-
neous activity.
Effect of CaMKII on RyR Phosphorylation, SR Ca21
Leak, and Spontaneous Ca21 Waves
Figure 6A shows that ouabain significantly increased the
phosphorylation of the CaMKII-dependent RyR residue,
Ser2814, and that this effect was prevented by 2.5 mmol/L
KN93. RyR phosphorylation can increase the sensitivity of
the channel for Ca21 release, promoting diastolic SR Ca21
leak and Ca21 waves.16 Using confocal imaging, we assessed
Ca21 spark frequency under resting conditions, which reflects
Ca21 leak from the SR.18 After 20 minutes of pacing rat
myocytes at 0.5 Hz in the presence of ouabain, pacing was
stopped, and Ca21 sparks were measured during 60 s. Figure
6B shows representative fluorescence images and overall
results demonstrating that ouabain increases spark frequency.
Additionally, we quantified the occurrence of spontaneous
Ca21 waves. Whereas in the absence of ouabain, myocytes
hardly showed Ca21 waves, ouabain treatment significantly
enhanced the number of spontaneous Ca21 waves from
0.0360.02 to 0.1060.01 waves* s21 (n58 cells from 4
hearts). KN93 prevented both the ouabain-induced increase in
Ca21 spark frequency and in Ca21 wave occurrence, indicat-
ing that CaMKII underlies these events.
CaMKII Inhibition Prevents Ouabain-Induced
Arrhythmias In Vivo
In the absence of ouabain, WT mice did not exhibit sponta-
neous arrhythmias as evidenced from continuous in vivo
Figure 4. Sarcoplasmic reticulum (SR)-targeted
calcium-calmodulin kinase II (CaMKII) inhibition
prevents ouabain-induced spontaneous activity. A,
Representative continuous chart recordings of cell
length show that in the presence of ouabain, wild-
type mice myocytes present a large number of
nonstimulated contractile events, whereas myocytes
from mice expressing the SR-targeted CaMKII inhib-
itor AIP have a reduced number of events. The bar
graph in B depicts the overall data of these experi-
ments. Data are medians6percentiles for n56
cells from 3 hearts per group (*P,0.05, Mann-
Whitney rank-sum test). C shows that SR-targeted
AIP does not significantly affect ouabain inotropy.
Data are means6SEM for n515 cells from 6
hearts.
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ECG measurements. As shown in Figure 7A, 10 mg/kg IP
administration of ouabain induced a variety of ECG altera-
tions in a background of sinus bradycardia and atrioventric-
ular block because of the vagal effects of ouabain. Among
these alterations, ventricular ectopic beats and sustained
ventricular tachycardia were the most common. These ar-
rhythmic events were diminished in the presence of KN93
(30 mmol/kg IP; n59; Figure 7B) and absent in SR-AIP mice
(n55; Figure 7C). Table shows the incidence of ventricular
ectopic beats and sustained ventricular tachycardia in the
presence of ouabain alone, ouabain1KN93, or SR-AIP mice
treated with ouabain. In addition, KN93 significantly reduced
ouabain-induced mice mortality. Nine out of 11 (18% sur-
vival) mice treated with ouabain died after treatment, whereas
6 out of 9 (67% survival) mice pretreated with KN93
(P50.04 vs ouabain) and 4 out of 5 SR-AIP (80% survival)
mice (P50.03 vs ouabain) survived ouabain treatment.
CaMKII Inhibition Prevents Digoxin-Induced
Spontaneous Activity
To examine whether the observed effect of ouabain on
spontaneous activity was common to other related cardiotonic
steroids, we studied the effect of digoxin (DIG) on the
number of NSE, SR Ca21 load, and Ca21 spark and wave
frequency in the absence and presence of KN93. Figure 8
shows that a low, nontoxic but inotropic dose of DIG
(10 mmol/L)19 does not increase the number of NSE nor the
frequency of spontaneous Ca21 waves. This dose of DIG
showed a tendency to increase SR Ca21 load and spark
frequency; however, these increases did not attain significant
levels. In contrast, 75 mmol/L DIG significantly increased the
number of NSE and SR Ca21 load as well as Ca21 spark and
wave frequency. Similar to the results obtained with ouabain,
CaMKII inhibition with KN93 did not prevent the DIG-
Figure 5. Effect of ouabain on sarcoplasmic reticulum (SR) Ca21 load and phospholamban phosphorylation. A, Representative blots
and overall results show that ouabain increases the phosphorylation of PLN at its Thr17 site and that KN93 prevents this increase. Data
are expressed as means6SEM from 5 independent experiments from 5 hearts (*P,0.05, 1-way ANOVA, Newman-Keuls). B, Typical
tracings and overall results of caffeine pulses performed to estimate SR Ca21 load in rat myocytes in the absence or presence of either
ouabain alone or ouabain1KN93. The bar graph below shows the average values of these experiments (*P,0.05, 1-way ANOVA,
Newman-Keuls; n58 cells from 4 hearts). C, Overall results of the effect of ouabain on the number of nonstimulated events in wild-type
(WT) and phospholamban double mutant myocytes (PLN-DM). Data are medians6percentiles from 6 cells from 3 hearts per group
(*P,0.05, Mann-Whitney rank-sum test).
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induced increase in SR Ca21 load but reduced the number of
NSE, as well as Ca21 spark and wave frequency.
Discussion
Steroidal glycosides extracted from the leaves of plants from
the genus Digitalis have been used for the treatment of
congestive heart failure for more than 200 years; however,
these compounds have a narrow therapeutic window because
of the presence of adverse toxic effects, characterized primar-
ily by arrhythmias and, as recently shown by us and others, by
apoptosis,2,8 which limit their extensive use in the clinical
practice. Digitalis-induced arrhythmogenic effects are, as yet,
not completely understood. It has been suggested that NCX-
mediated Ca21 influx, resulting in SR Ca21 overload,15 could
increase RyR open probability and lead to spontaneous
diastolic SR Ca21 release that could activate a transient Iti,
responsible for the generation of DADs, spontaneous action
potentials, and ventricular arrhythmias. A digitalis-induced
increase in Ca21i could also activate CaMKII, which has been
shown not only to favor SR Ca21 load but also to increase the
Ca21 sensitivity of the RyR and to induce arrhythmias.9,16
Thus, we hypothesized that CaMKII could be involved in
glycoside-induced arrhythmogenesis. In the present study, we
show that ouabain activates CaMKII, and, for the first time,
we demonstrate that ouabain-induced arrhythmias are
CaMKII-dependent. Furthermore, we show that ouabain pro-
motes CaMKII-dependent arrhythmogenesis both in vitro and
in vivo, and we demonstrate that CaMKII inhibition prevents
ouabain-induced arrhythmias without affecting its positive
inotropic effect, suggesting a potential therapeutic benefit for
CaMKII inhibition during glycoside treatment. Finally, our
results indicate that CaMKII-mediated phosphorylation of the
RyR, resulting in Ca21 leak from the SR and enhanced Ca21
wave formation, would be the underlying mechanism in-
volved. Highlighting the clinical relevance of our findings, it
is noteworthy that we obtained similar results using digoxin,
a structurally different cardiotonic steroid routinely used in
the clinical practice.
Figure 6. Effect of ouabain on ryanodine
receptor (RyR) phosphorylation, Ca21
spark and wave frequency. A, Represen-
tative blots and overall results show that
ouabain increases RyR Ser2814 phos-
phorylation and that KN93 prevents this
increase. Data are expressed as
means6SEM from 5 independent experi-
ments from 5 hearts (*P,0.05, 1-way
ANOVA, Newman-Keuls) B, Original con-
focal line-scan images of myocytes in the
absence of ouabain or either in the pres-
ence of ouabain alone or ouabain1KN93.
The bar graphs on the right indicate that
ouabain significantly increased Ca21
spark frequency and Ca21 wave occur-
rence and that these effects were inhibited
by KN93. Data are medians6percentiles for
6 to 8 cells from 3 hearts per group
(*P,0.05, Kruskal-Wallis 1-way ANOVA,
Dunn method).
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Ouabain Toxicity and CaMKII
It is now generally accepted that ouabain increases intracel-
lular Na1 through the inhibition of Na1/K1-ATPase. The
resulting reduction of the transarcolemmal Na1 gradient
favors the reverse mode of the NCX, which increases intra-
cellular Ca21 load and results in a positive inotropic effect. It
has been proposed that when this Ca21 load exceeds the
capacity of the SR, abnormal Ca21 release occurs, which, in
turn, triggers abnormal electric activity and arrhythmic con-
tractions. In the present study, we observed that ouabain
increased the activity of CaMKII (p-CaMKII) and that
ouabain-induced arrhythmic contractions were significantly
reduced by the CaMKII inhibitor KN93 (Figures 1 and 2).
These results indicate that CaMKII is involved in ouabain-
induced arrhythmogenesis. Further confirming the participa-
tion of CaMKII, we showed that (1) KN92, the inactive
analog of KN93, failed to affect ouabain-induced NSE; (2)
AIP, a structurally different inhibitor of CaMKII, also pre-
vented ouabain-induced NSE; (3) CaMKII overexpression
exacerbated ouabain-induced NSE; (4) transgenic mice ex-
pressing SR-targeted CaMKII inhibition (SR-AIP) were pro-
tected from the toxic effects of ouabain; and (5) in vivo,
ouabain failed to induce arrhythmias and death in WT mice
pretreated with KN93 and in SR-AIP mice. These findings
(combining pharmacological inhibition, genetic manipula-
tion, and in vivo studies) provide substantial evidence indi-
cating that CaMKII is mechanistically involved in ouabain-
induced spontaneous activity and arrhythmogenesis.
Mechanisms Underlying Ouabain-Induced
CaMKII-Dependent Arrhythmias
Cardiotonic steroid-induced arrhythmias have been shown to
be mediated by Ca21 waves, resulting in DADs, which
generate spontaneous action potentials.3,6 A potential role for
CaMKII in DADs formation has been previously re-
ported.12,20,21 Wu and colleagues were the first to describe
that CaMKII triggers an NCX-dependent arrhythmogenic
transient Iti through its effect of SR Ca21 load/release.20 Said
Figure 7. In vivo ECG of ouabain-induced arrhythmias in the absence and presence of calcium-calmodulin kinase II (CaMKII) inhibition.
Representative traces show the progressive effects of ouabain on cardiac rhythm (A), in the presence of KN93 (B), and in SR-AIP mice
(C). A shows that ouabain challenge is associated with ventricular escape beats (b), sustained monomorphic (c), and/or polymorphic (d)
ventricular tachycardia, followed by death. CaMKII inhibition (KN93 or SR-AIP mice) reduced the occurrence of these events. Note that
even though SR-AIP mice presented a pause in sinus rhythm, there were no associated escape ventricular beats (C, b).
Table. Frequency of Arrhythmias in Ouabain-Treated Mice
WT Mice
1Ouabain
WT Mice
1Ouabain1KN93
SR-AIP Mice
1Ouabain
No. of mice 11 9 5
Sinus bradycardia/AV
block
11 (100%) 9 (100%) 5 (100%)
Ventricular ectopic
beats (.1/h)
9 (81.2%) 3 (33.3%) 1 (20%)
Sustained VT 9 (81.2%) 2 (22.2%) 0 (0%)
Overall data shows the incidence of ventricular ectopic beats (premature or
escape beats) and sustained ventricular tachycardia in BALB/c mice in the
absence and presence of calcium-calmodulin kinase II inhibition (KN93 and
SR-AIP mice). Sustained ventricular tachycardia (VT) was defined as a run of
.10 ventricular ectopic beats.
WT indicates wild type; SR, sarcoplasmic reticulum.
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and colleagues showed that post acidosis-induced DAD-
triggered arrhythmias could be prevented by CaMKII inhibi-
tion and concluded that CaMKII would enhance SERCA2a
activity by phosphorylating phospholamban at its Thr17 site,
thus increasing SR Ca21 load and favoring DAD formation.21
Using a protocol similar to the one used in the present study,
Curran and colleagues also implicated CaMKII in DAD-
triggered arrhythmias of the failing heart.12 In this case, the
authors concluded that CaMKII increases the sensitivity of
the RyR, lowering the threshold for spontaneous Ca21 release
and thus providing the arrhythmogenic substrate. These
studies clearly define the 2 main factors responsible for
increasing the propensity for Ca21 waves and subsequent
DADs increased SR Ca21 load, and/or increased Ca21
sensitivity of the RyR. We showed that ouabain increased
both SR Ca21 load (Figure 5) and the phosphorylation of the
RyR associated with SR Ca21 leak (Figure 6), indicative of
increased Ca21 sensitivity of the RyR; however, CaMKII
inhibition, which prevented ouabain-induced arrhythmias, did
not affect SR Ca21 load, whereas it reduced RyR phosphor-
ylation, Ca21 leak, and Ca21 wave propensity (Figure 6).
Similar to the conclusion of Curran and colleagues, these
results suggest that CaMKII would primarily mediate
ouabain-induced arrhythmias through increasing the sensitiv-
ity of the RyR to Ca21. Our results showing that the
ouabain-induced increase in PLN Thr17 phosphorylation
could be prevented with KN93 seems to be at odds with the
failure of KN93 to reduce SR Ca21 load, given that this
phosphorylation is known to enhance SERCA2a activity and
SR Ca21 uptake; however, in the rat, a species with high
resting SR Ca21,22 ouabain can fully load the SR through
Ca21 influx via the NXC, and, therefore, CaMKII-dependent
PLN phosphorylation would not further increase SR Ca21
load. Our results showing that ouabain-induced spontaneous
contractile activity was similar between PLN-DM myocytes
and WT myocytes (Figure 5) would support the contention
that CaMKII-dependent PLN phosphorylation is not involved
in ouabain-induced arrhythmias; however, another possible
interpretation of our results is that Thr17 phosphorylation of
PLN does play a role in the arrhythmic pattern described,
Figure 8. Calcium-calmodulin kinase II
(CaMKII) inhibition reduces digoxin (DIG)-
induced increase in Ca21 spark and wave
frequency and prevents spontaneous
contractile activity. A, Overall results
show the effect of DIG in the presence
and absence of KN93 on the number of
nonstimulated events in rat myocytes.
Data are medians6percentiles from 5
cells from 3 hearts per group (*P,0.05,
Kruskal-Wallis 1-way ANOVA, Dunn
method). B, Overall results show the
effect of DIG in the presence and absence
of KN93 on sarcoplasmic reticulum (SR)
Ca21 load. Data are means6SEM from 5
cells from 3 hearts per group (*P,0.05,
1-way ANOVA, Newman-Keuls). C, Original
confocal line-scan images of myocytes in
the absence of DIG or either in the pres-
ence of 10 and 75 mmol/L DIG or DIG
75 mmol/L 1 KN93. The bar graphs on the
right indicate that DIG significantly
increased Ca21 spark frequency and Ca21
wave occurrence and that these effects
were inhibited by KN93. Data are
medians6percentiles from 5 cells from 3
hearts per group (*P,0.05, Kruskal-Wallis
1-way ANOVA-Dunn method).
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maintaining the increased SR Ca21 load produced by
ouabain, just matching the SR Ca21 leak produced by RyR
phosphorylation. If this were the case, one could further
speculate that PLN-DM mice might compensate for the lack
of PLN phosphorylation by the increase in L-type Ca21
channels, typical of these mice.23 In any case, our results
showing that KN93 completely prevents ouabain-induced
arrhythmias, without affecting SR Ca21 load, while prevent-
ing RyR phosphorylation, SR Ca21 leak, and Ca21 wave
propensity, would suggest that increased SR Ca21 load alone
is not sufficient to promote ouabain-induced arrhythmias.
Interestingly, the inverse conclusion seems to be also true, as
suggested by Eisner and colleagues, who elegantly showed
that increasing RyR receptor open probability alone is not
enough to produce arrhythmogenic diastolic Ca21 release and
that a parallel increase in SR Ca21 load is required.14 In the
case of ouabain, the NCX would provide Ca21 to load the SR
and activate CaMKII, which, in addition to other targets,
would phosphorylate the RyR and increase its Ca21 sensitiv-
ity, lowering the threshold for spontaneous Ca21 release.
Thus, the NCX would couple the arrhythmogenic RyR
phosphorylation with SR Ca21 overload that mediate the
spontaneous Ca21 waves, DADs, and eventually arrhythmias.
Indeed, several studies have pointed out the critical role of the
NCX in digitalis-induced arrhythmias.24,25
In a recent report, ouabain-triggered arrhythmias were
associated with mitochondrial dysfunction.26 This study con-
vincingly showed that ouabain-induced arrhythmias could be
prevented by blocking the mitochondrial NCX. These results,
obtained using a different species and by inducing arrhyth-
mias with ouabain plus isoproterenol, make direct compari-
sons to our results difficult; however, one explanation that
could reconcile the apparent discrepancies with our results is
that, in the context of ouabain challenge, mitochondrial NCX
activation could provide an additional source of Ca21 for
loading the SR and for CaMKII activation, thus its blockade
would reduce these processes and prevent arrhythmogenesis.
Consistent with our findings, several studies have demon-
strated that catecholaminergic polymorphic ventricular
tachycardia (an arrhythmic condition which resembles that of
digitalis-toxicity) is also linked to Ca21 leak from the SR and
can be triggered by ouabain.6 More importantly, catechol-
aminergic polymorphic ventricular tachycardia can be pre-
vented by CaMKII inhibition.27 These results not only dem-
onstrate the fundamental role of CaMKII in these types of
arrhythmias but also highlight the potential use of CaMKII
inhibition as a valid therapeutic option for both catechol-
aminergic polymorphic ventricular tachycardia and digitalis-
induced arrhythmias.
In summary, we have presented evidence indicating that
cardiotonic steroids activate CaMKII, which increases the
Ca21 sensitivity of the RyR, lowering the threshold for
spontaneous release and predisposing the heart for DAD-
triggered arrhythmias. These results highlight the need for a
redefinition of the mechanisms underlying digitalis-induced
arrhythmias in general, attributed almost exclusively to an
increase in SR Ca21 load. These findings could help to
explain the enhanced propensity for fatal arrhythmias ob-
served in heart failure patients, where high levels of endog-
enous ouabain-like compounds28 and CaMKII expression29
have been reported. Finally, although the benefit of glycoside
therapy in patients with endstage heart failure is widely
acknowledged, the finding that CaMKII inhibition prevents
ouabain-induced arrhythmias, without affecting its positive
inotropic effect, suggests the potential use of CaMKII inhib-
itors as an adjunct to digitalis treatment for cardiovascular
disease.
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CLINICAL PERSPECTIVE
Cardiac glycosides have been used for the treatment of congestive heart failure for more than 200 years; however, these
compounds have a narrow therapeutic window because of the presence of adverse toxic effects, including arrhythmias,
which limit their extensive use in the clinical practice. The arrhythmic effects have been proposed to occur when
sarcoplasmic reticulum (SR) Ca21 storage capacity is exceeded and spontaneous SR Ca21 release (Ca21 waves) arise and
activate a depolarizing current, which, if sufficiently large, may achieve threshold and generate spontaneous action
potentials and ventricular arrhythmias. In the present study, we show that cardiac glycoside activates calcium-calmodulin
kinase II (CaMKII), which phosphorylates the ryanodine receptor-favoring spontaneous SR Ca21 release, predisposing the
heart for delayed after depolarization-triggered arrhythmias. Our results also reveal that CaMKII inhibition prevents
digitalis-induced arrhythmias without affecting its positive inotropic effect, suggesting the potential use of CaMKII
inhibitors as an adjunct to digitalis for the treatment of heart failure. Thus, our findings could not only help to widen the
therapeutic window of cardiac glycosides but also help to explain the enhanced propensity for fatal arrhythmias observed
in heart failure patients, where high levels of endogenous ouabain-like compounds and CaMKII expression have been
reported.
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